Skip to content

Life Sciences

Every show filed under life sciences, ranked by what listeners actually play.

410
shows
0
subcategories
0
new this week

Most subscribed

video · in life sciences · refreshed hourly

Newest episodes

video · last seven days
  • Let's Talk Quality

    Small Dose #3: Ann Farnsworth on How to Onboard Your New Quality Hire

    This is Small Dose, our weekly series of short clips from Let’s Talk Quality. This week’s clip is from Episode 3 of Season 1, with Ann Farnsworth. Listen to the full episode on: Apple Podcasts: https://podcasts.apple.com/us/podcast/ann-farnsworth-on-how-to-create-an-onboarding/id1701837660?i=1000625389052 Spotify: https://open.spotify.com/episode/5e6zfvWgmABae4GnLZQPqY Connect with Ann on LinkedIn: https://www.linkedin.com/in/ann-farnsworth-6072725/

    Yesterday · 4 min· Video
  • Center of Excellence - Pharma 4.0 by Dr. Jayant Joshi

    Book Review – Cybersecurity for Pharma 4.0: The Executive Roadmap and Implementation Strategy

    Book Review – Cybersecurity for Pharma 4.0: The Executive Roadmap and Implementation Strategy How can pharmaceutical organizations accelerate digital transformation while ensuring cybersecurity, regulatory compliance, patient safety, and operational resilience? In this episode of Center of Excellence – Pharma 4.0, we present a review of Book 8 in the nine-book Cybersecurity for Pharma 4.0 series: Cybersecurity for Pharma 4.0: The Executive Roadmap and Implementation Strategy, co-authored by Dr. Jayant Joshi and Umesh Naik. As pharmaceutical organizations increasingly adopt Artificial Intelligence, smart manufacturing, cloud platforms, connected supply chains, and other digital technologies, cybersecurity must evolve from a technical IT function into a strategic leadership priority. This book addresses the critical challenge of translating cybersecurity vision into structured, measurable, and enterprise-wide implementation. Rather than offering another catalogue of cybersecurity technologies, this volume provides a practical executive implementation playbook that connects boardroom strategy with shop-floor execution. What Does This Book Cover? The book is structured around four key chapters, providing pharmaceutical leaders with a systematic approach to cybersecurity implementation: The Five-Phase Cybersecurity Implementation Roadmap A structured journey from strategic assessment to continuous improvement: Assessment and Vision Governance and Architecture Pilot Implementation Enterprise-Wide Scaling Continuous Improvement The roadmap helps organizations assess critical systems, data flows, suppliers, and GxP risks before establishing governance structures, validating pilot initiatives, and scaling successful security controls across the enterprise. Leadership Implementation Strategy Cybersecurity requires ownership beyond the IT department. This chapter provides ten strategic leadership recommendations, ten common implementation pitfalls, a leadership dashboard, and a practical 100-day action plan. The 100-day plan establishes a phased approach to implementation, covering organizational visibility, governance priorities, and controlled execution. It emphasizes the shared responsibility of CEOs, Quality Assurance, Manufacturing, Supply Chain, OT, IT, and cybersecurity leadership. Cybersecurity Documentation Master Checklist Regulatory compliance and inspection readiness depend on reliable, accessible evidence. This chapter introduces a comprehensive documentation framework covering six important areas: Governance Computerized System Lifecycle Data Integrity Cybersecurity Supply Chain AI and Emerging Technologies It also presents a five-level documentation maturity assessment to help organizations identify gaps, assign responsibilities, strengthen record control, and maintain inspection readiness throughout the system lifecycle. Cybersecurity KPIs and KRIs Effective cybersecurity governance requires measurable performance and risk indicators. The book explains how Key Performance Indicators (KPIs) and Key Risk Indicators (KRIs) can help leadership evaluate security effectiveness, identify emerging threats, and make evidence-based decisions. Examples include validated-system coverage, high-risk vulnerabilities, backup restoration success, supplier assessments, audit-trail anomalies, cold-chain excursions, and recall traceability time. What Makes This Book Valuable? The distinctive strength of this volume is its ability to connect strategic cybersecurity objectives with practical implementation. It brings together: A five-phase enterprise implementation roadmap. A practical 100-day leadership action plan. A comprehensive documentation and audit-readiness framework. Measurable cybersecurity KPIs and KRIs. Clear leadership responsibilities and implementation priorities. Who Should Read This Book? This book is particularly relevant for: CEOs and Board Members: Strengthening cybersecurity oversight and investment prioritization. CIOs, CISOs and IT Leaders: Developing and implementing enterprise cybersecurity strategies. Quality and Regulatory Leaders: Improving compliance, documentation, and inspection readiness. Manufacturing and OT Leaders: Securing connected manufacturing environments and operational systems. Supply Chain Leaders: Addressing third-party and supply chain cybersecurity risks. Pharmaceutical Digital Transformation Leaders: Scaling digital initiatives while maintaining security and resilience. Explore this book and strengthen your organization's approach to cybersecurity implementation. Listen, learn, and lead the Pharma 4.0 transformation! Resources: Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB Book Series: Cybersecurity for Pharma 4.0 https://www.amazon.com/dp/B0HFW5988N Podcast: https://pharma4coe.podbean.com YouTube Channel: https://www.youtube.com/@COE-PHARMA4.0 Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/ Website: https://respa.com #CybersecurityForPharma40 #Pharma40 #PharmaceuticalCybersecurity #Cybersecurity #PharmaLeadership #DigitalTransformation #PharmaIndustry #GxPCompliance #DataIntegrity #RegulatoryCompliance #CyberResilience #InformationSecurity #OTSecurity #ITSecurity #SmartManufacturing #PharmaDigitalTransformation #RiskManagement #CybersecurityStrategy #CenterOfExcellencePharma40 #BookReview

    Yesterday · 9 min· Video
  • Migraine Relief Code with Dr. Amelia Scott Barrett, MD

    Migraines: There's More to it Than Taking a Pill

    In this episode, Dr. Amelia Scott Barrett, MD, and Dr. Myra Reed discuss how shift away from mainstream medicine towards a more functional and integrative medicine approach can improve health overall and reduce migraines in particular. They explore how lifestyle medicine, lab testing, and strong rapport can improve follow-through and support better outcomes. The conversation also covers common migraine triggers such as food, sleep, and toxins, along with how functional medicine approaches are expanding the tools available for individualized care. (0:00) Welcome and changing the mindset around health care (4:37) Less medication, more listening, and advanced testing (10:08) Migraine, food triggers, toxins, and functional medicine

    Thursday · 19 min· Video
  • The State of TMF

    TMF Standard Model V1: From Reference Model to Digital Standard

    Two years in development, the TMF Standard Model V1 draft opens for community review on October 19. What changes for your team? Paul Carter and Christina Mantzioros explain what V1 is and how it differs from the TMF Reference Model. You'll hear why V1 is a digital, evidence-based standard built around ICH E6(R3). You'll also hear about the features that set V1 apart: record groups and record types, stable unique identifiers, and one model covering drugs, biologics, medical devices, IVDR, RWE, and the investigator site file. You'll learn how V1 gives you consistent, machine-readable TMF content you exchange across systems and organizations. You'll also learn the steps your team should take now to prepare. Learn more about community review and compare your current TMF structure against the new record groups and types: https://www.cdisc.org/public-review/cdisc-tmf-standard-model-v1-community-review Signup to our upcoming product showcase where we'll perform a live demo of AI-assisted indexing in eTMF Connect: https://montrium.registration.goldcast.io/webinar/a9580101-3715-4c26-8d88-f6154a53a77d CHAPTERS: 0:00 Why regulators say less is more 0:59 Welcome to Episode 28 1:27 Why the TMF Reference Model needed to change 10:00 Will a standard mean less flexibility? 13:51 The new V1 structure 17:38 From 246 artifacts to 557 record types 21:30 From documents to records and evidence 22:38 How V1 maps to ICH E6(R3) 24:14 Why Core and Recommended go away 26:32 Poll on V1’s impact on the industry 29:28 Poll on when teams plan to adopt V1 34:02 Q&A on the TMF as an essential records ecosystem 38:15 Q&A on visualizing record groups and record types 39:08 Q&A on using metadata to tell the story of a study 42:46 Q&A on getting functional areas to own their records 46:04 No more record type for relevant communications and notes to file 48:57 Wrap up 49:49 November 18 product showcase on AI-assisted indexing (check the description to sign up)

    Thursday · 51 min· Video

Video in Life Sciences10